EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whey Protein Peptides Self-Assembled Nanoparticles with Intrinsic Cholesterol Esterase Inhibition Enhance Stigmasterol Bioaccessibility and Hypocholesterolemic Effects

Haoyu Wang iD, Zhiyuan Ma iD, Han Gong iD, Yang Zou, Haijiao Zhang, Xiaohong Chen, Xueying Mao iD

Nutrients · 07.09.2026 · 18 (17) · 2934

DOI: 10.3390/nu18172934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 07.09.2026. Verfasst von Haoyu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijin…. Hauptthemen laut MEDLINE: Nanoparticles, Whey Proteins, Anticholesteremic Agents, Sterol Esterase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Beijing Livestock Industry Innovation Team, Beijing Livestock Industry Innovation Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stigmasterol (St) holds promise as a natural cholesterol-lowering agent, yet its poor aqueous solubility and low bioaccessibility severely constrain its application in functional foods.

Methods

In this study, we exploited whey protein peptides (WPP) with intrinsic cholesterol esterase (CEase) inhibitory activity to construct St-loaded self-assembled nanoparticles. Subsequently, we investigated its physicochemical properties and formation mechanism and evaluated its hypocholesterolemic activity through animal experiments.

Results

Driven by non-covalent hydrophobic and hydrogen-bonding interactions, the optimized St-loaded WPP nanoparticles (St@WPP) ((234.47 ± 1.36) nm) achieved a high encapsulation efficiency (EE) of 74.73% ± 2.19%. This nano-encapsulation markedly improved St dispersibility and storage stability, and significantly elevated its bioaccessibility from 9.00% ± 0.14% to 19.41% ± 0.69% after simulated gastrointestinal digestion. St@WPP administration effectively ameliorated dyslipidemia, as evidenced by reduced serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), which may be associated with reduced intestinal cholesterol availability and increased fecal cholesterol content. Moreover, St@WPP alleviated hepatic steatosis, attenuated systemic inflammation, and rebalanced gut microbiota architecture.

Conclusions

Collectively, the WPP shell functions as a delivery carrier that improves the water solubility and bioaccessibility of St, thereby broadening its potential for application in low-fat or aqueous-based food systems. The resulting St@WPP exhibits notable cholesterol-lowering activity, positioning it as a promising functional food ingredient with potential benefits for cholesterol management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesWhey ProteinsAnticholesteremic AgentsSterol EsterasePeptidesAnimalsBiological AvailabilityBioactive Peptides, DietaryMaleCholesterol

Stichwörter der Autor:innen

bioaccessibilitycholesterol esterase inhibitionhypocholesterolemic efficacyself-assembled nanoparticlesstigmasterolwhey protein peptides

Substanzen

Whey ProteinsAnticholesteremic AgentsSterol EsteraseBioactive Peptides, DietaryPeptidesCholesterol

Autor:innen und Institutionen

  • Key Laboratory of Functional Dairy, Ministry of Education, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
  • Key Laboratory of Functional and Flavor Dairy Processing, Ministry of Agriculture, Tianjin Haihe Dairy Co., Ltd., Tianjin 300300, China.

ORCID-Profile: Haoyu Wang, Zhiyuan Ma, Han Gong, Xueying Mao

Förderung

  • National Natural Science Foundation of China
  • the Beijing Livestock Industry Innovation Team
  • Beijing Livestock Industry Innovation Team

Zitieren

APA

Wang, H., Ma, Z., Gong, H., Zou, Y., Zhang, H., Chen, X., & Mao, X. (2026). Whey Protein Peptides Self-Assembled Nanoparticles with Intrinsic Cholesterol Esterase Inhibition Enhance Stigmasterol Bioaccessibility and Hypocholesterolemic Effects. Nutrients, 18(17), 2934. https://doi.org/10.3390/nu18172934

Vancouver

Wang H, Ma Z, Gong H, Zou Y, Zhang H, Chen X, et al. Whey Protein Peptides Self-Assembled Nanoparticles with Intrinsic Cholesterol Esterase Inhibition Enhance Stigmasterol Bioaccessibility and Hypocholesterolemic Effects. Nutrients. 2026;18(17):2934. doi:10.3390/nu18172934

BibTeX
@article{Wang2026,
  author = {Wang, Haoyu and Ma, Zhiyuan and Gong, Han and Zou, Yang and Zhang, Haijiao and Chen, Xiaohong and Mao, Xueying},
  title = {Whey Protein Peptides Self-Assembled Nanoparticles with Intrinsic Cholesterol Esterase Inhibition Enhance Stigmasterol Bioaccessibility and Hypocholesterolemic Effects},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {17},
  pages = {2934},
  doi = {10.3390/nu18172934}
}
Kostenlos starten →